Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System

GuruFocus.com11-05

Nuwellis (NASDAQ:NUWE), this Minneapolis-based medical device company saw its shares rise by 121.32% today as the US government decided to raise the reimbursement rate for ultrafiltration that is ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481530071?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/i00gJ_aFxHHLjDZatWAysQ--~B/aD0zNjc7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/107289ced6e8b2ded9f6d7c330bf5ada","is_english":true,"pubTime":"2024-11-05 02:43","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2481530071","market":"us","top_or_hot":-1,"title":"Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System","media":"GuruFocus.com","content":"<div>\n<p>Nuwellis (NASDAQ:NUWE), this Minneapolis-based medical device company saw its shares rise by 121.32% today as the US government decided to raise the reimbursement rate for ultrafiltration that is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/nuwellis-stock-soars-121-major-184343829.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-05 02:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/nuwellis-stock-soars-121-major-184343829.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nuwellis (NASDAQ:NUWE), this Minneapolis-based medical device company saw its shares rise by 121.32% today as the US government decided to raise the reimbursement rate for ultrafiltration that is ...</p>\n\n<a href=\"https://finance.yahoo.com/news/nuwellis-stock-soars-121-major-184343829.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://finance.yahoo.com/news/nuwellis-stock-soars-121-major-184343829.html","article_id":"2481530071","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/i00gJ_aFxHHLjDZatWAysQ--~B/aD0zNjc7dz01NTA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/107289ced6e8b2ded9f6d7c330bf5ada"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481530071","pubTimestamp":1730745823,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Nuwellis , this Minneapolis-based medical device company saw its shares rise by 121.32% today as the US government decided to raise the reimbursement rate for ultrafiltration that is conducted using the Nuwellis' Aquadex System.Nuwellis is a medical device company that specializes in producing the Aquadex SmartFlow system to do the ultrafiltration procedure for patients with fluid overload. Ultrafiltration process is used for eliminating extra amounts of fluid in patients with heart failure or kidney illness.The US government through Centers for Medicare and Medicaid Services  revealed that it will adjust the payment per day for the ultrafiltration procedures that use the Nuwellis' Aquadex system from $413 a day to $1,639 starting from the 1 st of January 2025.While for Nuwellis, higher reimbursement rate will increase the amount of revenues that Nuwellis can earn from each procedure using the Aquadex and encourage the healthcare providers to perform ultrafiltration using their Aquadex","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","LU2346227817.USD":"BGF SUSTAINABLE GLOBAL INFRASTRUCTURE \"A2\" (USD) ACC","LU2637428348.USD":"NORDEA 1 GLOBAL SUSTAINABLE LISTED REAL ASSETS \"MP\" (USD) INC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","BK4082":"医疗保健设备","NUWE":"Nuwellis, Inc.","BK4585":"ETF&股票定投概念","CMS":"CMS能源","BK4208":"复合型公用事业"},"translate_title":"Aquadex系统报销大幅增加，Nuwellis股价飙升121%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CMS":1,"NUWE":1},"content_text":"Nuwellis (NASDAQ:NUWE), this Minneapolis-based medical device company saw its shares rise by 121.32% today as the US government decided to raise the reimbursement rate for ultrafiltration that is conducted using the Nuwellis' Aquadex System. \nNuwellis is a medical device company that specializes in producing the Aquadex SmartFlow system to do the ultrafiltration procedure for patients with fluid overload. Ultrafiltration process is used for eliminating extra amounts of fluid in patients with heart failure or kidney illness. \n\nWarning! GuruFocus has detected 4 Warning Signs with NUWE.\n\nThe US government through Centers for Medicare and Medicaid Services (CMS) revealed that it will adjust the payment per day for the ultrafiltration procedures that use the Nuwellis' Aquadex system from $413 a day to $1,639 starting from the 1 st of January 2025. \nThis equates to a lot more money in the pocket of healthcare providers for each procedure and this increased reimbursement will definitely be beneficial to both the patient and the healthcare provider. Patients can improve access to this treatment, while healthcare providers can have resources to train their staff to perform the procedure. \nWhile for Nuwellis, higher reimbursement rate will increase the amount of revenues that Nuwellis can earn from each procedure using the Aquadex and encourage the healthcare providers to perform ultrafiltration using their Aquadex and at the end create higher demand for the device.Higher revenue may be translated into better financial position, fund their research and development in the future and do marketing. This good news led to a boost in the company's stock price and benefited shareholders.\n\nThe chart above shows the fact that Nuwellis has been operating in the net loss linestyle for more than 10 years but the company has been increasing in revenues in the most recent years. These consistent annual revenues ignited positive prospects signaling that Nuwellis could turn profitable in future in case of sustaining this trend.\nDon't just read the latest news - make informed investment decisions. Visit GuruFocus today and dive deeper into Nuwellis' performance with Charts & Guru insights.This article first appeared on \nGuruFocus.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481530071"}